Hengrui USA                                                                                                              Page 1 of 1
Protocol No.: SHRUS 1001                                                                                                            
                                              Table 14.5.1 Summary of Metastatic Disease                                            
____________________________________________________________________________________________________________________________________

                                                                         Placebo                  Low Dose                 High Dose
____________________________________________________________________________________________________________________________________

Any Metastatic Disease                                                                                                              
Yes                                                                    1 (100.0)                 4 ( 80.0)                 3 ( 75.0)
No                                                                     1 (100.0)                 1 ( 20.0)                 1 ( 25.0)

Location of Metastatic Disease                                                                                                      
Bone                                                                   1 (100.0)                 2 ( 40.0)                 1 ( 25.0)
Brain                                                                  1 (100.0)                 2 ( 40.0)                 1 ( 25.0)
Other                                                                  1 (100.0)                         0                 1 ( 25.0)
Chest Wall                                                             1 (100.0)                         0                 1 ( 25.0)
































____________________________________________________________________________________________________________________________________
Note: This is based on the dataset ADSL.                                                                                            
Program Source: t2.sas                                                                                  Executed: (Draft) 2022-01-14
